Could cannabis extract ease autism symptoms? new trial aims to find out.
NCT ID NCT07257939
First seen Dec 29, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tests whether a full-spectrum cannabis plant extract called NTI164 can reduce core autism symptoms like social difficulties and repetitive behaviors. About 98 children and young adults aged 6 to 25 with moderate to severe autism will receive either NTI164 or a placebo for 16 weeks. Researchers will measure changes using standard autism rating scales and blood tests to understand how the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Monash Health
Clayton, Victoria, 3168, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.